These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9927994)

  • 1. Solution structure comparison of the VIP/PACAP family of peptides by NMR spectroscopy.
    Wray V; Nokihara K; Naruse S
    Ann N Y Acad Sci; 1998 Dec; 865():37-44. PubMed ID: 9927994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural simplification of potent growth hormone-releasing hormone analogs: implications for other members of the VIP/GHRH/PACAP family.
    Coy DH; Jiang NY; Fuselier J; Murphy WA
    Ann N Y Acad Sci; 1996 Dec; 805():149-58. PubMed ID: 8993400
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor.
    Uchida D; Tatsuno I; Tanaka T; Hirai A; Saito Y; Moro O; Tajima M
    Ann N Y Acad Sci; 1998 Dec; 865():253-8. PubMed ID: 9928019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
    Ando E; Nokihara K; Naruse S; Wray V
    Biomed Pept Proteins Nucleic Acids; 1996; 2(2):41-6. PubMed ID: 9346825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speculations on the mechanism of hormone-receptor interactions of the secretin/glucagon family of polypeptide hormones derived from computational structural studies.
    Momany FA; Bowers CY
    Ann N Y Acad Sci; 1996 Dec; 805():172-81; discussion 181-3. PubMed ID: 8993402
    [No Abstract]   [Full Text] [Related]  

  • 9. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide.
    Champion HC; Santiago JA; Garrison EA; Cheng DY; Coy DH; Murphy WA; Ascuitto RJ; Ross-Ascuitto NT; McNamara DB; Kadowitz PJ
    Ann N Y Acad Sci; 1996 Dec; 805():429-41; discussion 442. PubMed ID: 8993422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PACAP-VIP hybrid peptides on gastric blood flow in conscious dogs.
    Naruse S; Nakamura T; Wei M; Ando E; Nokihara K; Wray V; Ozaki T; Kitagawa M; Hayakawa T
    Ann N Y Acad Sci; 1996 Dec; 805():511-5. PubMed ID: 8993432
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationship studies of PACAP-27 and VIP analogues.
    Kashimoto K; Nagano Y; Suitani Y; Hamanaka K; Mizumoto T; Tomizaki K; Takahata H; Nagamoto A; Ohata A; Yoshihara S; Ichimura T
    Ann N Y Acad Sci; 1996 Dec; 805():505-10. PubMed ID: 8993431
    [No Abstract]   [Full Text] [Related]  

  • 15. Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase.
    Chartrel N; Wang Y; Fournier A; Vaudry H; Conlon JM
    Endocrinology; 1995 Jul; 136(7):3079-86. PubMed ID: 7540547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.
    Inagaki N; Kuromi H; Seino S
    Ann N Y Acad Sci; 1996 Dec; 805():44-51; discussion 52-3. PubMed ID: 8993392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy.
    Wray V; Kakoschke C; Nokihara K; Naruse S
    Biochemistry; 1993 Jun; 32(22):5832-41. PubMed ID: 8504103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.